Truqap is really a kinase inhibitor that works by blocking pathways that aid the cancer cells endure and grow, so reduces most cancers progress. Truqap is from a class of medicines named an AKT inhibitor. Truqap acquired FDA approval on November 17, 2023, immediately after favourable effects within the CAPItello-291 https://charlesj665xit8.blog5star.com/profile